University of Texas/Texas AM Investment Management Co (UTIMCO)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.97M Buy
+165,020
New +$4.32M 0.46% 44
2026
Q1
Sell
-100,701
Closed -$2.51M 360
2025
Q4
$2.51M Buy
+100,701
New +$2.54M 0.35% 53
2022
Q1
Sell
-84
Closed -$5K 35
2021
Q4
$5K Buy
+84
New +$4.16K ﹤0.01% 32
2015
Q4
Sell
-105
Closed -$3K 33
2015
Q3
$3K Buy
+105
New +$3.37K ﹤0.01% 21

Other funds holding PFE

University of Texas/Texas AM Investment Management Co (UTIMCO)'s PFE Position: Q2 2026 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) opened a new position in Pfizer (PFE) in Q2 2026: 165,020 shares worth $3.97M. The stake represents 0.46% of the portfolio and ranks #44 among its holdings. This is a return to the name: University of Texas/Texas AM Investment Management Co (UTIMCO) previously reported a position in PFE as recently as Q4 2025.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in PFE in Q3 2015 and has held it in 4 quarters since. 2,239 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • University of Texas/Texas AM Investment Management Co (UTIMCO) held 165,020 shares of Pfizer worth $3.97M as of Q2 2026.
  • Pfizer was a new University of Texas/Texas AM Investment Management Co (UTIMCO) position in Q2 2026.
  • Pfizer made up 0.46% of University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio in Q2 2026, its #44 holding.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in Pfizer in Q3 2015 and has held it in 4 quarters since.
  • 2,239 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q2 2026, filed 3 Aug 2026.